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Abstract
The objective of this study was to evaluate the effectiveness of the SurePure Turbulator
ultraviolet-C (UV-C, 254 nm wavelength) irradiation equipment on inactivation of different
enveloped and non-enveloped viruses in commercially collected liquid animal plasma. Spe-
cifically, Pseudorabies virus (PRV), Porcine reproductive and respiratory syndrome virus
(PRRSV), Porcine epidemic diarrhea virus (PEDV), Bovine viral diarrhea virus (BVDV),
Classical swine fever virus (CSFV), Swine influenza virus (SIV) as enveloped viruses and
Porcine parvovirus (PPV), Swine vesicular disease virus (SVDV), Porcine circovirus type 2
(PCV-2) and Senecavirus A (SVA) as non-enveloped viruses, were inoculated in bovine or
porcine plasma and subjected to different UV-C irradiation doses (0, 750, 1500, 3000, 6000
and 9000 J/L) using an UV-C device developed for opaque liquid working under turbulent
flow. The enveloped viruses tested were inactivated at < 3000 J/L of UV-C, being the dose
needed to inactivate 4 log TCID50 (4D) of 1612 J/L for PRV,1004 J/L for PRRSV, 1953 J/L
for PEDV, 1639 J/L for SIV, 1641 J/L for CSFV and 1943 J/L for BVDV. The non-enveloped
viruses tended to have higher 4D values: 2161 J/L for PPV, 3223 J/L for SVA and 3708 J/L
for SVDV. Because the initial viral concentration was <4.0 Log for PCV-2, it was not possible
to calculate the 4D value for this virus. In conclusion, these results demonstrated that the
SurePure Turbulator UV-C treatment system is capable of inactivating significant levels of
swine viruses inoculated in commercially collected porcine or bovine plasma. It was
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concluded that irradiation with UV-C can provide an additional redundant biosafety feature
in the manufacturing process of spray-dried animal plasma.
Introduction
Spray-dried animal plasma (SDAP) is a protein source widely used in pig feed due to its func-
tional components able to improve post-weaning performance and survival [1,2]. The
manufacturing process of SDAP involves the collection of blood from healthy animals at a
commercial abattoir that have been inspected by veterinary officials and passed as fit for
slaughter for human consumption. Immediately after collection, the blood is treated with an
anticoagulant, chilled, transported to the manufacturing plant and centrifuged to obtain
plasma and blood cell fractions. Alternatively, the blood can be centrifuged at the abattoir and
the plasma fraction is chilled and transported to the manufacturing plant. At the manufactur-
ing plant, the plasma is concentrated by membrane filtration and spray-dried, achieving 80˚C
throughout its substance [2]. The process for the production of SDAP has been validated to
effectively inactivate many viral and bacterial pathogens [3–14]. These data demonstrate that
commercially produced SDAP is a safe feed ingredient. However, it is appropriate to evaluate
new technology that could be included into the manufacturing process representing added
redundant microbial inactivation steps. Typical plasma manufacturing plants are capable of
processing between 25,000 mt to 450,000 mt of liquid plasma annually.
Many different techniques have been used to inactivate or remove viruses from human
plasma products, i.e. intravenous immunoglobulin (IVIG). For example, solvent/detergent
mixtures have been effectively used to inactivate lipid enveloped viruses [15]. However, this
process requires significant volume of solvent/detergent mixtures that must be removed and
disposed. Enveloped viruses can be inactivated by the addition of unsaturated fatty acids [16],
or caprylic acid in combination with low pH and temperature [17,18]. While many of these
methods are very effective for plasma fractions (purified immunoglobulins or albumin) these
methods are not appropriate for the production of SDAP because these processes result in
many denatured plasma proteins. As a rule, non-enveloped viruses are more resistant to inacti-
vation than enveloped viruses [19]. An alternative to inactivation is removal of the virus from
plasma fractions by nanofiltration [20]. However, this is not a practical option for industrial
production of SDAP since the volume of product to be processed is very large and most pro-
teins are retained in the retentate. Similarly, other removal procedures used in the human
plasma industry, like precipitation or chromatography are impractical due to the large volumes
used by SDAP manufacturing industry.
Ultraviolet-C (UV-C) radiation represents an alternative to chemical inactivation methods
[21]. Such methodology uses a shortwave electromagnetic radiation with a wavelength of 254
nm (range of 250 and 270 nm), which induces damage in the nucleic acids. UV-C radiation
disrupts DNA and RNA [22], and is therefore effective at inactivating a wide range of microor-
ganisms. In fact, it has been extensively used for disinfection of water, surfaces and food prod-
ucts [23,24]. The inability of UV-C radiation to penetrate opaque liquids can be overcome by
introducing adequate turbulence insuring that all of the liquid is exposed to the surface of the
UV-C light [25–30]. UV-C treatment has been shown to reduce bacterial contamination while
not inactivating protein functionality or growth enhancing properties of SDAP [31]. SurePure
has designed a UV-C treatment system that is able to reduce the pathogen burden in milk,
fruit juices, etc. [26,28,29].
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The objective of this study was to assess inactivation efficiency of the SurePure Turbulator
UV-C irradiation system with selected swine enveloped viruses Pseudorabies virus (PRV), Por-
cine reproductive and respiratory syndrome virus (PRRSV), Porcine epidemic diarrhea virus
(PEDV), Bovine viral diarrhea virus (BVDV), Swine influenza A virus (SIV) and Classical
swine fever virus (CSFV) and non-enveloped viruses Porcine parvovirus (PPV), Swine vesicular
disease virus (SVDV), Porcine circovirus 2 (PCV-2) and Senecavirus A (SVA) inoculated in liq-
uid bovine or porcine plasma. These viruses were selected because of their economic impact in
livestock production and as models of viruses from different families with various genome
type and size.
Material and methods
Viral strains and culture conditions
Pseudorabies virus. Pseudorabies virus strain NIA3 [32], kindly supplied by Joan Plana
(Fort Dodge Veterinaria, Vall de Bianya, Spain), was propagated in the PK-15 cell line (pro-
vided by the Institute of Virology (UE and OIE Reference Laboratory for CSFV, Hannover),
using a standard growth media (SGM) containing minimum essential medium eagle (MEM-E;
ThermoFisher, Waltham, MA, USA) supplemented with 1% penicillin 10,000 U/mL and strep-
tomycin 10 mg/mL (ThermoFisher), 0.5% Nystatin 10,000 IU/mL (Sigma-Aldrich), 1% L-glu-
tamine 200 mM (ThermoFisher) and 5% of heat inactivated fetal bovine serum tested free for
virus and antibodies against pestiviruses (FBS; BioWest, Miami, FL, USA). PK-15 cells were
grown in 175-cm2 flasks (Corning, Corning, NY, USA), and when cells were confluent, the
medium was discarded and adsorption was performed at a MOI 0.01. Virus stock was pro-
duced in the same cells to obtain 84 mL with a viral titer of 108.95 TCID50/mL that was used to
inoculate 24 L of bovine plasma, achieving a final viral titer of 106.5 TCID50/mL.
Porcine reproductive and respiratory syndrome virus. Porcine reproductive and respira-
tory syndrome virus VP21 strain [33] was propagated in the Marc-145 cell line (ATCC
CLR12231) grown in SGM with 5% FBS. Cells were cultured in 75-cm2 flasks. When cells were
confluent, the media was discarded and the adsorption was done using the virus at a MOI
0.01. After 1.5 hours at 37˚C, inoculum was removed and 30 mL of medium were added. This
procedure was repeated until achieving 1,800 mL of viral suspension with a titer of 105.57
TCID50/mL that was used to inoculate 24 L of bovine plasma achieving a final viral titer of
104.42 TCID50/mL.
Porcine epidemic diarrhea virus. Porcine epidemic diarrhea virus CV777 strain [34],
kindly provided by Dr. Hans Nauwynck (University of Ghent, Belgium), was propagated in
VERO cells (ATCC CCL-81) grown in SGM with 10% FBS. Cells were cultured in 175-cm2
flasks and when they were confluent, the media was removed and cells were rinsed twice with
PBS. Finally, inoculum was added at MOI 0.001 and adsorption was done for 1 hour at 37˚C.
Subsequently, the inoculum was discarded, flasks were rinsed twice with PBS and MEM-E was
supplemented with 1% penicillin 10,000 U/mL and streptomycin 10 mg/ml (ThermoFisher),
0.5% Nystatin (10,000 U/mL), 1% L-glutamine (200 mM), 0.05% trypsin and 0.3% tryptose.
The viral stock was produced in the same cells to obtain 2,110 mL of suspension with a viral
titer of 105.42 TCID50 /mL that was used to inoculate 24 L of bovine plasma achieving a final
viral titer of 104.7 TCID50 /mL.
Bovine viral diarrhea virus. Bovine viral diarrhea virus NADL was provided by the Insti-
tute of Virology (UE and OIE Reference Laboratory for CSFV, Hannover) and was propagated
in MDBK cells (provided by the Institute of Virology (UE and OIE Reference Laboratory for
CSFV, Hannover), grown in SGM with 5% FBS tested free of pestivirus antibodies. Cells were
cultured in 175-cm2 flasks. Media was discarded and the adsorption was done on confluent
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cells using BVDV strain at a MOI 0.01. After 1.5 hours at 37˚C, inoculum was removed and 50
mL of medium were added. This procedure was repeated until getting 255.3 mL of a suspen-
sion with a titer of 107.87 TCID50/mL that was used to inoculate 24 L of porcine plasma achiev-
ing a final viral titer of 104.5 TCID50/mL.
Classical swine fever virus. Classical swine fever virus strain Alfort 187, provided by the
Institute of Virology (UE and OIE Reference Laboratory for CSFV, Hannover), was propagated
in the PK-15 cell line (provided by the same Institute of Virology, Hannover), grown in SGM
supplemented with 5% of FBS free from pestivirus antibodies. A total of 160 mL of virus stock
solution was produced in the same cells at a MOI 2, for a virus titer of 107.36 TCID50 /mL that
was used to inoculate 24 L of bovine plasma achieving a final viral titer of 105.19 TCID50 /mL.
Swine influenza virus. Swine influenza virus strain H1N1 A/Swine/Spain/SF11131/2017
[35] was propagated in MDCK cell line (ATCC CCL-34) grown in DMEM (ThermoFisher,
Waltham, MA, USA) supplemented with 1% penicillin (10,000 U/mL), 1% streptomycin
(10mg/mL; ThermoFisher), 0.5% Nystatin (10,000 U/mL; Sigma-Aldrich), 1% L-glutamine
200mM; ThermoFisher) and 5% FBS. Cells were cultured in 175-cm2 flasks. When cells were
confluent, the media was discarded and the adsorption was done at MOI 0.1. After 1 hour at
37˚C, inoculum was removed and 30 mL of medium were added. With this procedure, 300 mL
of viral suspension with a final virus titer of 107.2 TCID50 /mL that was used to inoculate 24 L
of bovine plasma achieving a final viral titer of 105.3 TCID50/mL.
Senecavirus A. Senecavirus A isolate BRA/UEL-PR/15 was kindly provided by Dr.
Amauri Alfieri (Universidade Estadual de Londrina, Londrina, Brazil) and was propagated in
PK-15 cell line (provided by the Institute of Virology (UE and OIE Reference Laboratory for
CSFV, Hannover), grown in SGM with 10% FBS. Viral infection was done in confluent 175
cm2 flasks at a MOI 0.001. After 1 hour of absorption, 50 mL of SGM were added. CPE was vis-
ible at 72 h and the flasks were frozen. Following this procedure 1,100 mL of SVA with a titer
of 106.76 TCID50/mL was produced, that was used to inoculate 24 L of bovine plasma achieving
a final viral titer of 105.43 TCID50/mL.
Swine vesicular disease virus. Swine vesicular disease virus, strain UK-72, was provided
by David K.J. Mackay (European Community Reference Laboratory for Foot and Mouth Dis-
ease, Institute for Animal Health. Pirbright, UK) to Laboratorio de Sanidad Animal (Barce-
lona). SVDV was propagated in SK-RST cell line (ATCC CRL-2842), grown in SGM
supplemented with 5% FBS. A virus stock was produced using the same cell line at MOI 0.001
to obtain 24 mL of a virus stock solution with a titer of 107.38 TCID50 /mL that was used to
inoculate 24 L of bovine plasma achieving a final viral titer of 106.00 TCID50 /mL.
Porcine circovirus 2. Porcine circovirus 2 genotype b isolate Sp-10-7-54-13 [36] was cul-
tured in the PK-15 cell line (provided by the Institute of Virology (UE and OIE Reference Lab-
oratory for CSFV, Hannover), grown in SGM with 10% FBS. A mix of 6 mL of virus stock and
7 x 106 PK-15 cells resuspended in 50 mL of MEM-E (MOI 0.1) were added in 175 and 25 cm2
flasks. At 24 hours cells were treated with glucosamine to facilitate the virus infection. Forty-
eight hours later, viral infection was checked by IPMA [37] in the 25 cm2 flask. If more than 25
positive cells were counted in a microscope field, the 175 cm2 flask was trypsinized and the
cells were transferred to 3 new 175 cm2 flasks. The process was repeated until 2,316 mL of
virus stock with a titer of 104.79 TCID50 /mL that was used to inoculate 24 L of bovine plasma
achieving a final viral titer of 103.76 TCID50% /mL.
Porcine parvovirus. Porcine parvovirus strain NADL-2 was kindly provided by Dr Albert
Bosch (Department of Genetics, Microbiology and Statistics School of Biology, University of
Barcelona, Spain). It was propagated in SK-RST cells (ATCC CRL-2842), grown in SGM sup-
plemented with 5% FBS. One mL of virus stock and 9 mL of MEM-E supplemented with 1%
pyruvate (Merck KGaA, Darmstadt, Germany) were added to a conical tube with 16 x 106 SK-
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6 cells and shaken for 30 minutes at 104 rpm and 37˚C. After that time, the contents of the
tube were transferred to a 175 cm2 flask, in which 40 mL of MEM-E supplemented with 1%
pyruvate were added. This procedure was repeated until obtaining 811 mL of viral suspension
with a titer of 106.91 TCID50% /mL that was used to inoculate 24 L of bovine plasma achieving a
final viral titer of 105.44 TCID50 /mL.
Genomic data and virion size of each virus used in this study are displayed in Table 1.
Plasma
Bovine and porcine blood was obtained from EU inspected slaughter facilities from animals
inspected and approved for slaughter for human consumption. Blood was collected in stainless
steel containers with sodium phosphate as anticoagulant. Blood was refrigerated and trans-
ported to the APC Europe laboratory (APC-Europe S.L.U., Granollers, Spain) and plasma was
separated by centrifugation. Plasma was frozen at -20˚C.
Prior to virus inoculation and UV-C irradiation, plasma was thawed and filtered to elimi-
nate potential cryoprecipitate. Before virus inoculation, a 100-mL sample of plasma was stored
at –80˚C to determine absence of the test virus and absence of neutralizing antibodies to the
test virus.
For all viruses tested, after virus inoculation to plasma, the 24 L mixture was divided into
three equal 8 L aliquots. Each aliquot was subjected to UV-C irradiation to provide triplicate
analytical results.
Virus inoculation in plasma procedure
Because antibodies against porcine viruses are not expected to be found in bovine blood,
bovine plasma was inoculated with PRV, PRRSV, PEDV, CSFV, SIV, SVA, SVDV, PPV and
PCV-2. Subsequent test confirmed the bovine plasma was negative for specific antibodies
against the test virus. Similarly, porcine plasma was tested for BVDV antibodies by neutraliz-
ing peroxidase monolayer assay.
Settings of UV-C system
The UV-C reactor system SurePure Turbulator used for the study was designed for opaque liq-
uids, manufactured by SurePure Operation AG (Zug, Switzerland) and is described elsewhere
[30]. Briefly, the system consists of a reactor with a stainless-steel inlet and outlet chamber
with a stainless steel corrugated spiral tube between the chambers. Inside the spiral tube is an
UV-C 254 nm wavelength germicidal lamp of 100-Watt (W) output (30 W UV-C output)
Table 1. Virion size and genome characteristics of the viruses used in the study.
VIRUS FAMILY ENVELOPE GENOME SIZE (nm) GENOME SIZE (Kb)
PRV Herpesviridae Yes dsDNA 150–180 143.46
PRRSV Arteriviridae Yes (+)ssRNA 50–65 15.43
PEDV Coronaviridae Yes (+)ssRNA 95–190 28.03
BVDV Flaviviridae Yes (+)ssRNA 25–120 12.57
CSFV Flaviviridae Yes (+)ssRNA 25–120 12.3
SIV Orthomyxoviridae Yes (-)ssRNA 80–120 13.15
SVA Picornaviridae No (+)ssRNA 30 7.31
PPV Parvoviridae No ssDNA 18–26 5.07
PCV2 Circoviridae No ssDNA 17 1.77
SVDV Picornaviridae No (+)ssRNA 22–30 7.39
https://doi.org/10.1371/journal.pone.0212332.t001
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protected by a quartz sleeve. The liquid flows between the corrugated spiral tube and the
quartz sleeve. The tangential inlet of the reactor creates a high velocity and turbulence in the
inlet chamber and brings the liquid close to contact with the surface of the UV-C light source.
The liquid is pumped at a minimum flow rate of 4000 L/h with a Reynolds value in excess of
7500 (Reynolds number > 2,600 indicates a turbulent flow).
The UV-C dosage is expressed as J/L. The operation time of the UV-C treatment is based
on the quantity of product to be treated and the flow rate of the product feed. At a flow rate of
4000 L/h, 9 s are required for 10 L of product to pass through the reactor once; thus, one turn
of the product through the system is equivalent to a UV-C dose of 22.95 J/L. The UV dosage
per L of liquid treated for one reactor with continuous flow was calculated as follows: Dosage =
Total UV-C output per unit (W) / Flow rate (L/s) = 25.50 W / 1.11 L/s = (25.50 J/s)/ (1.11
L /s) = 22.95 J/L. Using an ammeter, the input current to the machine and its consumption
were checked and it was established that they were appropriate according to the technical spec-
ifications and the data sheet of the UV-C lamp provided by SurePure.
A standard ‘Cleaning in Place’ (CIP) process as described by Keyser et al. [38] based on a
treatment with NaOH 5%, was implemented prior to and following each UV-C treatment.
Sampling
Plasma flow was stabilized at 4000 L/h with the UV lamp switched off. After 5 minutes of stable
flow, a positive control (0 J/L) sample was collected into sterile container. Then, the UV-C
lamp was switched on and irradiation started. 175 mL of treated plasma were collected into
sterile containers at different UV-C doses (750, 1500, 3000, 6000, and 9000 J/L).
Analysis of viral titration
Infectivity of samples was determined in target cell cultures using the microtiter assay proce-
dure [39]. The microtiter assay was done in a 96-well plate for all tested viruses, except for
PEDV. Titration of virus was done using the whole plate for every dilution, from -1 to -5 dilu-
tions, to amplify the detection capability of the test. Final titer was expressed as log TCID50/
mL. Once all samples were titrated and the first negative dose was found, further steps were
developed to ensure full inactivation of the samples. First, 50 mL of this negative dose sample
were inoculated into 10 175-cm2 culture flasks and incubated at 37˚C for 5 days. The flasks
were frozen and thawed three times. The liquid was then centrifuged at 3000 rpm and 25 mL
were inoculated into 5 175-cm2 flasks. The flasks were incubated 5 days at 37˚C. The proce-
dure was repeated again and, finally, only one flask was inoculated with 5 mL and incubated at
37˚C for 5 days. If the final flask was negative, it was considered that no viral particles were
present in the initial sample; if the final flask was found positive, a titration of the plasma was
repeated again on ten 96-well plates to analyze a total volume of 50 mL.
Due to the cytotoxic effect of the plasma, strong washes to eliminate serum used to propa-
gate the cell culture and trypsin addition, PEDV was titrated by means of PFU/mL. A 12-well
culture plate with 100% confluency was inoculated with diluted plasma in MEM supplemented
with 0.05% trypsin and 0.3% tryptose, but without FBS. Whole plates were used for each dilu-
tion, from -1 to -5, to amplify the detection capability of the test. Conversion to TCID50/mL
was done multiplying PFU x 0.7 (https://www.lgcstandardsatcc.org/support/faqs/48802/
Converting+TCID50+to+plaque+forming+units+PFU-124.aspx?geo_country=es). Negative
samples were inoculated to 175-cm2 culture bottles to analyze a total volume of 50 mL (10 mL
by bottle), and passaged three times before being discarded as negative. If a sample was found
positive, a titration of pure plasma was repeated on 10 12-well plates to analyze the same total
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volume of 50 mL. This procedure was intended to increase 10 times the initial analyzed
volume.
Modeling of inactivation
Microbial inactivation due to thermal and non-thermal processes can be represented by eight
possible curves [40]. The GInaFiT software was used to test linear and non-linear survival
curves [40], using the biphasic [41],Weibull [42], Weibull plus tail [43] and biphasic plus
shoulder [40] models. The GInaFiT software has been used to test survival kinetics of different
bacteria and viruses when submitted to heat treatment or UV-C irradiation [44].
The biphasic model [40,41] uses the Eq (1):
log10ðNÞ ¼ log10ðN0Þ þ log10 ðf � e  kmax1t þ ð1   f Þ � e  kmax2tÞ ð1Þ
Where N0 is the initial bacterial concentration; t is time; f is the fraction of the initial popula-
tion in a major subpopulation, (1-f) is the fraction of the initial population in a minor subpop-
ulation, and kmax1 and kmax2 are the specific inactivation rates of the two populations,
respectively.
The Weibull model [42] shows the Eq (2):
log10 Nð Þ ¼ log10 Nð0Þð Þ   ð
t
d
Þ p ð2Þ
Where δ is a scale parameter denoted as the time for the first decimal reduction, and p is the
shape parameter that describes concavity or convexity of the curve. If p>1 the curve shows
convexity and if p<1 the curve is concave.
The Weibull plus tail model [43] uses the Eq (3):
log10 Nð Þ ¼ log10 ðð10logN0   10logNresÞÞ � 10  
t
dð Þ
p
þ 10logNres ð3Þ
Where Nres is the number of resistant microorganism subpopulation.
The Biphasic plus shoulder model [40] follows the Eq (4):
log 10ðNÞ ¼ log 10 N0ð Þ
þ log 10 f � expð  kmax 1 � tÞ �
expðkmax1 � SlÞ
1þ ðexpðkmax1 � SlÞ   1 � expð  kmax1 � tÞÞ þ 1ð1   fÞ � expð  kmax2 � tÞ � expðkmax1�SlÞ
ð1þðexpðkmax 1�SlÞ  1Þ�expð  kmax 1�tÞÞ
kmax2
kmax1
0
@
1
Að4Þ
Where N0 is the initial bacterial concentration; t is time; kmax1 and kmax2 are the specific inacti-
vation rates of the two populations and S1 are the degrees of freedom used for the parameter
estimation by GInaFiT
The Log linear model [40] presents the Eq (5):
log10 Nð Þ ¼ log10 Nð0Þð Þ   ð
Kmax � t
Lnð10Þ
Þ ð5Þ
Where N represents de microbial cell density, N0 the initial microbial cell density, t is time;
kmax is the first order inactivation constant and Ln(10) represents de decimal reduction time.
The log-linear plus tail model [40,45] uses the Eq (6):
logN ¼ logðð10log N0   10logNresÞÞ   e ðkmax dÞ þ 10logNres ð6Þ
Where kmax is the inactivation rate of the log linear part of the curve and Nres is the number of
resistant microorganism subpopulation.
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The log-linear plus Shoulder model [40,45] shows the Eq (7):
log10 Nð Þ ¼¼ log10 10log10ðNð0ÞÞ   10log10ðNresÞÞ � eKmax�t � exp   Kmax 1 � tð Þ � ð
eKmax1�Sl
1þ ðeKmax1�Sl   1Þ � eKmax1�t
� �
þ 10log10ðNresÞ ð7Þ
Where N0 is the initial bacterial concentration; t is time; kmax is the inactivation rate and S1
are the degrees of freedom.
Using these equations, the software automatically calculates the 4D value (the dose needed
to inactivate 4 log of viral load). In the case of BVDV, since the titer expressed as Log TCID50/
mL did not achieve 4 log, the 4D value was calculated for Log TCID50 in 10 mL of tested sam-
ple. In the case of PCV2, the 4D value could not be calculated due to the process did not
achieve 4 log of inactivation.
Statistical analyses
Data were expressed as the mean as Log10 TCID50 with standard deviations of three indepen-
dent replicates. Mean, standard deviations, ANOVA and F-Test for comparisons were calcu-
lated with Excel 2007 (Microsoft Office). The Tukey test was done to determine significant
differences between UV-C radiation doses. Mean square error (MSE), goodness of fit in terms
of root mean square error (RMSE), correlation coefficient (R2) and adjusted correlation coeffi-
cient (adj-R2) values were calculated with the GInaFiT software [40]. The inactivation model
with the best fit corresponded to the model with the smallest RMSE [40].
Results
Bovine plasma used in the studies was negative for viral contamination or neutralizing anti-
bodies against tested viruses (PRV, PRRSV, PEDV, CSFV, SIV, SVA, SVDV, PPV and PCV-
2). In addition, porcine plasma was free from BVDV and BVDV antibodies.
The results of UV-C viral inactivation are summarized in Table 2 and in Figs 1, 2 and 3.
In general, all enveloped viruses tested were inactivated at<3000 J/L and showed non-lin-
ear inactivation kinetics, biphasic or Weibull distributions, with low RMSE values resulting in
4D values under 3000 J/L (Figs 1 and 2 and Table 2). The two best non-linear inactivation
kinetics with the smallest RMSE are included in Table 2.
Greater ranges of stability were found for non-enveloped viruses. PPV was inactivated at
<3000 J/L, but other non-enveloped viruses such as SVA, SVDV and PCV-2 required a greater
UV-C dose to be inactivated (Table 2; Fig 3). For example, all three samples of SVDV at 6000
J/L were negative by the microtiter assay. However, the subsequent 3 blind passages performed
for each 6000 J/L sample were positive. Afterwards, a titration of 25 mL was done by duplicate,
obtaining one positive out of 960 wells, so, it was concluded that there were 0.02 particles/mL
(0.014 TCID50%) in the 6000 J/L samples (1 particle/50 mL assayed volume). To further con-
firm the dose required to inactivate SVDV, three additional blind passages were performed for
the three samples irradiated at 9000 J/L, and one was found positive. Titration of the original
sample of 9000 J/L (25 mL) was done; one out of 480 inoculated wells was positive. It was cal-
culated that 0.04 particles per milliliter (0.028 TCID50%) were still present in the only positive
sample of 9000 J/L (1 particle / 25 mL assayed volume). The most resistant virus was PCV-2,
since the total log10 reduction achieved was 2.71 log10 at 9000 J/L.
Discussion
The efficacy of microbial reduction by UV-C treatment of liquids depends on different factors,
including the microorganism used, the opaqueness of the liquid, the presence of suspended
particles, and the microbial contamination level at the starting point [46]. Animal plasma from
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slaughterhouse is an opaque liquid; therefore, UV-C radiation does not penetrate this liquid.
This problem has been overcome by introducing turbulent flow achieving that the whole vol-
ume of liquid passes close to the UV-C radiation source [25–30]. The UV-C system used in
this work can be expanded to efficiently process large volumes of liquid compatible with com-
mercial production of fruit juices, wine [26,38] and milk [47]. It is important to differentiate
this unique design of the SurePure Turbulator system for treatment of high volume of opaque
liquids from other UV systems developed for treatment of human plasma fractions [25,27]
that are designed for treatment of small plasma fraction bags under gentle agitation but cannot
be scalable to the volumes used by the commercial SDAP industry.
A preliminary step to implement industrial plasma irradiation with UV-C consisted of
demonstrating such treatment does not affect the functionality of proteins present in SDAP.
Similar growth and health performance of pigs fed diets with UV-SDAP versus non-irradiated
SDAP has been reported [31,48].
The next step was to investigate the inactivation capacity of the system on possible contami-
nating viruses in the plasma. For this purpose, selected viruses representing enveloped and
non-enveloped, DNA and RNA, single-stranded and double-stranded viruses of importance
for porcine industry were spiked into SDAP and irradiated. Furthermore, the different viruses
Table 2. Log reduction of viral titers expressed as Log 10 TCID50 at different UV-C doses and statistical parameters of models for inactivation of enveloped or non-
enveloped viruses.
Parameter PRV PRRSV PEDV BVDV† SIV CSFV SVDV PCV-2 PPV SVA
Theoretical viral titer in
24 L
6.5 4.42 4.7 4.5 5.3 5.19 6 3.76 5.44 5.43
Viral titer (VT) before
UV-C irradiation
4.53±0 4±0.1 4.07±0.11 4.16±0.24 5.09±0.05 4.09±0.02 4.08±0 3.26±0.12 4±0.06 4.68±0.18
VT at 750 J/L 3.78±0.49 1.33±0.08 2.02±0.42 3.36±0.13 4.06±0.05 3.23±0.13 4.08±0.04 1.68±0.04 3.23±0.12 4.12±0.06
VT at 1500 J/L 1.36±0.07 BDL 1.19±0.35 1.63±0.08 1.65±0.06 0.64±0.03 1.69±0.04 1.54±0.05 1.69±0.04 2.99±0.06
VT at 3000 J/L 0.02±0.01 BDL BDL BDL BDL BDL 1.46±0.01 1.48±0.01 BDL 0.94±0.1
VT at 6000 J/L BDL1 BDL BDL BDL BDL BDL 0.02±0.01 0.73±0.04 BDL BDL
VT at 9000 J/L BDL BDL BDL BDL BDL BDL 0.04±0.02 0.55±0.01 BDL BDL
Best Fit model Weibull + tail Log
linear
Biphasic Weibull Biphasic +
shoulder
Biphasic +
shoulder
Log
linear + tail
Biphasic Log linear +
shoulder
Biphasic +
shoulder
MSE1 0.0195 0.0238 0.0662 0.0193 0.0023 0.0049 0.3195 0.0144 0.0054 0.0099
RMSE2 0.1398 0.1543 0.2574 0.1389 0.0478 0.0703 0.5653 0.1199 0.0733 0.0993
R-Square 0.9978 0.9966 0.9898 0.9979 0.9998 0.9994 0.9499 0.9855 0.9992 0.9988
R-Square adjusted 0.9970 0.9961 0.9859 0.9975 0.9997 0.9991 0.9432 0.9824 0.9990 0.9983
4D reduction (J/L) 1612 1004 1953 1943 1639 1641 3708 NC 2161 3223
Second Best Fit model Biphasic +
shoulder
Weibull Weibull Log linear +
shoulder
Log linear +
shoulder
Weibull Weibull +
tail
Weibull Weibull Biphasic
MSE2 0.0223 0.0272 0.0834 0.0389 0.0380 0.1955 0.3423 0.0233 0.0076 0.0395
RMSE3 0.1494 0.1650 0.2888 0.1973 0.1948 0.4421 0.5850 0.1528 0.0873 0.1988
R-Square 0.9978 0.9967 0.9855 0.9959 0.9958 0.9717 0.9499 0.9748 0.9988 0.9947
R-Square adjusted 0.9965 0.9955 0.9823 0.9949 0.9949 0.9654 0.9392 0.9714 0.9985 0.9932
4D reduction (J/L) 1786 1004 1953 1861 1723 1872 3708 NC4 2190 3050
1BDL: Below Detection Limit, being the limit of detection for each batch 1/50 mL = 0.02 viral particles/mL
2MSE: Mean Sum of Squared Error.
3 RMSE: Root Mean Sum of Squared Error. This parameter determines the model that best fits the data.
4NC: Not able to calculate due to the initial titer lower than 104 TCID50/mL.
†Viral titer calculated for 10 mL of analysed sample.
https://doi.org/10.1371/journal.pone.0212332.t002
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tested may be considered surrogates for other untested viruses belonging to the same family or
genus, although it is always recommended to test specifically each particular virus [49].
In the present study, UV-C radiation was more effective inactivating tested enveloped
viruses compared to the non-enveloped viruses. Enveloped viruses could not be detected
when the UV-C dose was>3000 J/L. The best fit lines describing inactivation kinetics of the
Fig 1. Mean PRV, PRSSV, CSFV and BVDV log 10/mL values after UV-C irradiation of bovine plasma at different UV irradiation doses. Blue
diamonds indicated measured results of the viral titer at different UV-C irradiation doses expressed as mean log 10/mL (n = 3 replicates). Red line is the
identified inactivation curve model. �: indicates a value below the detection limit.
https://doi.org/10.1371/journal.pone.0212332.g001
Fig 2. Mean PEDV and SIV log 10/mL values after UV-C irradiation of bovine plasma at different UV irradiation doses. Blue diamonds indicated
measured results of the viral titer at different UV-C irradiation doses expressed as mean log 10/mL (n = 3 replicates). Red line is the identified
inactivation curve model. �: indicates a value below the detection limit.
https://doi.org/10.1371/journal.pone.0212332.g002
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enveloped viruses were curvilinear biphasic equations. This could be due to lack of more
points of collection; in many cases the last data point(s) appeared to be beyond the minimum
UV-C radiation required to inactivate the entire virus in the sample, creating an apparent cur-
vilinear shape. Cutler et al, [50] reported biphasic inactivation kinetics of PRRSV, BVDV and
SIV using a different UV-C delivery system and with the virus suspended in culture media
rather than blood plasma. Although almost a lineal response was observed in the present
study, the best model for BVDV was Weibull, and biphasic plus shoulder for SIV. Nevertheless,
in both studies, despite using two different irradiation equipment (here versus the used by
Cutler et al. [49]), the relative sensitivity of the virus to UV-C inactivation was similar with
PRRSV being more sensitive than BVDV or SIV.
A total inactivation (3.16 log) of BVDV was achieved at 3000 J/L. The inactivation kinetics
obtained with BVDV is very similar to the one observed in the other tested pestivirus, CSFV,
which could indicate that members of the same genus could respond similarly to UV-C
treatment.
PRV titer decreased more than 4 log at UV-C irradiation treatment < 3000 J/L, which rep-
resented a better inactivation ratio than that reported by another experiment using Riboflavin-
UV photochemical based technology [49]. The degree of inactivation by UV-C irradiation
may depend on the technology used [51].
To the authors’ knowledge, this is the first study showing effective results in the inactivation
of PEDV by means of UV-C.
Fig 3. Mean PCV-2, SVDV, PPV, and SVA log 10/mL values after UV-C irradiation of bovine plasma at different UV irradiation doses. Blue
diamonds indicated measured results of the viral titer at different UV-C irradiation doses expressed as mean log 10/mL (n = 3 replicates). Red line is the
identified inactivation curve model. �: indicates a value below the detection limit.
https://doi.org/10.1371/journal.pone.0212332.g003
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The non-enveloped viruses that were tested appeared to be more resistant to inactivation by
UV-C radiation. The inactivation curve for PPV was consistent with previously published data
[31], with apparent linear inactivation in response to increasing UV-C dose. Likewise, the
inactivation curve for SVA appeared to be linear except for the highest UV-C dose. The inacti-
vation curve for SVDV showed minimal inactivation at low UV-C dose, suggesting that a min-
imal UV-C dose was necessary before virus was inactivated. This has been reported by others
[40] who suggested that for some virus inactivation does not occur until a minimum UV-C
dose is achieved. However, in this experiment appears to be another shoulder in the inactiva-
tion curve at intermediate UV-C dosage (1500 and 3000 J/L). Furthermore, while the highest
doses appeared to inactivate all the virus, subsequent passages detected very low residual viral
infectivity. The inactivation curve for PCV-2 demonstrated that UV-C radiation inactivated
this virus; however, even at the highest dose (9000 J/L), residual levels of PCV-2 were recov-
ered. The presence of a resistant viral subpopulation has been attributed to the ability of some
viruses to take advantage of host cell repair mechanisms [52], or in some cases they can code
for their own repair machinery [53]. It has also been argued that viral particle clumping, par-
ticularly with other cells or debris, may shield some virus from UV-C radiation [50].
In the present study, a difference between the theoretical titer in the spiked plasma and the
measured titer at time zero was observed. The difference was greater with enveloped viruses
than with non-enveloped viruses. Generally, enveloped viruses are more sensitive to environ-
mental conditions such as salts, temperature changes, freezing and thawing or presence of
anticoagulants [19] and could explain the reduction in titer before irradiation compared to the
theoretical titer [4].
There was not a clear relationship between rate of inactivation and genome type or size.
Theoretically, DNA is more sensitive to UV-C due to the presence of thymine [54]. In contrast,
DNA repair can reduce the UV-C effect, especially for dsDNA viruses [55]. In the present
study, PRV (a dsDNA virus) had 4D reduction estimated at 1612 J/L, which was not apparently
different from the 4D reduction values obtained for other tested RNA viruses (PEDV and
SIV). Obtained results with viruses evaluated in this study suggest that UV-C inactivation sus-
ceptibility of both types of viral genome was similar.
It has been suggested that the longer the genome, the higher the susceptibility to UV-C
damage [56]. However, based on the present results, increased genome size did not appear to
increase virus susceptibility to UV-C radiation when spiked into commercially collected ani-
mal plasma and exposed to UV-C. Only a weak linear trend (r2 = 0.43) was found in the cur-
rent data when comparing genome size to the 4D of viruses (without outlier’s results PEDV
and PRV). Curiously, Wang et al. [25] found that viruses with large genomes (Adenovirus and
Reovirus) were inactivated with higher UV-C doses than viruses with shorter genomes. These
authors indicated that their unexpected survival curves compared with other UV-C irradiation
studies was difficult to explain, and suggested differences in the shape, size and lamp geometry
of UV-irradiation systems as well as in protein concentrations and composition of process
streams to explain their results. Also, genome configuration may affect the virus sensitivity to
UV-C radiation. For example, both PPV and PCV-2 have a relatively small genome size (5.07
and 1.77 Kb, respectively). However, estimated 4D for PPV was 2161 J/L while that for PCV-2
was>9000 J/L. It is possible that the linear configuration of PPV genome could be more easily
damaged, whereas the circular genome of PCV-2 may provide resistance to the formation of
thymidine dimers by UV-C radiation. In any case, the present study should be considered
exploratory in nature regarding the relationship between size and type of the genome and sus-
ceptibility to inactivation by UV-C irradiation.
In addition to the photochemical damage of UV-C irradiation on nucleic acids, UV-C also
induces reactive oxygen species that may interact with the external lipid bilayer membrane of
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enveloped viruses [57], causing lipid peroxidation [58]. This effect may further explain why
enveloped viruses were very susceptible to UV-C irradiation. In fact, in the present study, irra-
diation doses used were between 30–375 times higher than those described in the literature
[59]. These differences could be due to the presence of proteins and other molecules in solu-
tion, to the possibility of virus clumping with these molecules, to the greater opacity of the liq-
uid against UV, to the higher basal absorbance and/or to the darker color of the liquid plasma
solution compared to other more transparent solution like water or other buffers like PBS.
Nevertheless, our results are closer to irradiation values found in other opaque raw materials
like milk or juices [26,60].
Overall, the SurePure UV-C Turbulator design was effective in inactivating a wide variety
of virus spiked into commercially collected liquid animal plasma. Data from the present study
indicated that the UV-C irradiation of liquid plasma is a technology that could provide an
additional inactivation step to the industrial production process for SDAP. Exposure to UV-C
is extensively used for the disinfection of liquid media and surfaces due to its germicidal activ-
ity [23,24]. Therefore, UV-C irradiation of liquid plasma during the manufacturing process for
SDAP has a potential application for inactivation of microbial contaminants without causing
negative effects on the nutritional or physical qualities of the treated material [51,61]. Further-
more, the UV-C mechanism of inactivation (DNA or RNA damage) is different than the ther-
mal inactivation provided by the spray-drying step. In consequence, the UV-C step can be
considered independent from the spray-drying process and may be a synergistic process as
both procedures have different inactivation targets.
In conclusion, obtained results demonstrate UV-C as a suitable technology to be applied in
the manufacturing process of SDAP as a redundant biosafety step for the inactivation of
viruses of concern for the livestock industry.
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